Global MicroRNA Sequencing (miRNA-Seq) Market Research Report 2024

Publication ID:

PB505250850

Publication Date:

May 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.
The global MicroRNA Sequencing (miRNA-Seq) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for MicroRNA Sequencing (miRNA-Seq) in Academic & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of MicroRNA Sequencing (miRNA-Seq) include Illumina, Thermo Fisher, Qiagen, Perkinelmer, Takara Bio, New England Biolabs, Norgen Biotek, Trilink Biotechnologies and Lexogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for MicroRNA Sequencing (miRNA-Seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MicroRNA Sequencing (miRNA-Seq).
Report Scope
The MicroRNA Sequencing (miRNA-Seq) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MicroRNA Sequencing (miRNA-Seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MicroRNA Sequencing (miRNA-Seq) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
SOLiD
Nanopore Sequencing
Segment by Application
Academic & Research Institutes
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MicroRNA Sequencing (miRNA-Seq) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MicroRNA Sequencing (miRNA-Seq) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 SOLiD
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global MicroRNA Sequencing (miRNA-Seq) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic & Research Institutes
1.3.3 CROs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global MicroRNA Sequencing (miRNA-Seq) Market Perspective (2019-2030)
2.2 MicroRNA Sequencing (miRNA-Seq) Growth Trends by Region
2.2.1 Global MicroRNA Sequencing (miRNA-Seq) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 MicroRNA Sequencing (miRNA-Seq) Historic Market Size by Region (2019-2024)
2.2.3 MicroRNA Sequencing (miRNA-Seq) Forecasted Market Size by Region (2025-2030)
2.3 MicroRNA Sequencing (miRNA-Seq) Market Dynamics
2.3.1 MicroRNA Sequencing (miRNA-Seq) Industry Trends
2.3.2 MicroRNA Sequencing (miRNA-Seq) Market Drivers
2.3.3 MicroRNA Sequencing (miRNA-Seq) Market Challenges
2.3.4 MicroRNA Sequencing (miRNA-Seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MicroRNA Sequencing (miRNA-Seq) Players by Revenue
3.1.1 Global Top MicroRNA Sequencing (miRNA-Seq) Players by Revenue (2019-2024)
3.1.2 Global MicroRNA Sequencing (miRNA-Seq) Revenue Market Share by Players (2019-2024)
3.2 Global MicroRNA Sequencing (miRNA-Seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MicroRNA Sequencing (miRNA-Seq) Revenue
3.4 Global MicroRNA Sequencing (miRNA-Seq) Market Concentration Ratio
3.4.1 Global MicroRNA Sequencing (miRNA-Seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MicroRNA Sequencing (miRNA-Seq) Revenue in 2023
3.5 MicroRNA Sequencing (miRNA-Seq) Key Players Head office and Area Served
3.6 Key Players MicroRNA Sequencing (miRNA-Seq) Product Solution and Service
3.7 Date of Enter into MicroRNA Sequencing (miRNA-Seq) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MicroRNA Sequencing (miRNA-Seq) Breakdown Data by Type
4.1 Global MicroRNA Sequencing (miRNA-Seq) Historic Market Size by Type (2019-2024)
4.2 Global MicroRNA Sequencing (miRNA-Seq) Forecasted Market Size by Type (2025-2030)
5 MicroRNA Sequencing (miRNA-Seq) Breakdown Data by Application
5.1 Global MicroRNA Sequencing (miRNA-Seq) Historic Market Size by Application (2019-2024)
5.2 Global MicroRNA Sequencing (miRNA-Seq) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America MicroRNA Sequencing (miRNA-Seq) Market Size (2019-2030)
6.2 North America MicroRNA Sequencing (miRNA-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2019-2024)
6.4 North America MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe MicroRNA Sequencing (miRNA-Seq) Market Size (2019-2030)
7.2 Europe MicroRNA Sequencing (miRNA-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2019-2024)
7.4 Europe MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific MicroRNA Sequencing (miRNA-Seq) Market Size (2019-2030)
8.2 Asia-Pacific MicroRNA Sequencing (miRNA-Seq) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific MicroRNA Sequencing (miRNA-Seq) Market Size by Region (2019-2024)
8.4 Asia-Pacific MicroRNA Sequencing (miRNA-Seq) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America MicroRNA Sequencing (miRNA-Seq) Market Size (2019-2030)
9.2 Latin America MicroRNA Sequencing (miRNA-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2019-2024)
9.4 Latin America MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MicroRNA Sequencing (miRNA-Seq) Market Size (2019-2030)
10.2 Middle East & Africa MicroRNA Sequencing (miRNA-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2019-2024)
10.4 Middle East & Africa MicroRNA Sequencing (miRNA-Seq) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina MicroRNA Sequencing (miRNA-Seq) Introduction
11.1.4 Illumina Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher MicroRNA Sequencing (miRNA-Seq) Introduction
11.2.4 Thermo Fisher Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.2.5 Thermo Fisher Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen MicroRNA Sequencing (miRNA-Seq) Introduction
11.3.4 Qiagen Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer MicroRNA Sequencing (miRNA-Seq) Introduction
11.4.4 Perkinelmer Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.4.5 Perkinelmer Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio MicroRNA Sequencing (miRNA-Seq) Introduction
11.5.4 Takara Bio Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 New England Biolabs
11.6.1 New England Biolabs Company Detail
11.6.2 New England Biolabs Business Overview
11.6.3 New England Biolabs MicroRNA Sequencing (miRNA-Seq) Introduction
11.6.4 New England Biolabs Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.6.5 New England Biolabs Recent Development
11.7 Norgen Biotek
11.7.1 Norgen Biotek Company Detail
11.7.2 Norgen Biotek Business Overview
11.7.3 Norgen Biotek MicroRNA Sequencing (miRNA-Seq) Introduction
11.7.4 Norgen Biotek Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.7.5 Norgen Biotek Recent Development
11.8 Trilink Biotechnologies
11.8.1 Trilink Biotechnologies Company Detail
11.8.2 Trilink Biotechnologies Business Overview
11.8.3 Trilink Biotechnologies MicroRNA Sequencing (miRNA-Seq) Introduction
11.8.4 Trilink Biotechnologies Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.8.5 Trilink Biotechnologies Recent Development
11.9 Lexogen
11.9.1 Lexogen Company Detail
11.9.2 Lexogen Business Overview
11.9.3 Lexogen MicroRNA Sequencing (miRNA-Seq) Introduction
11.9.4 Lexogen Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.9.5 Lexogen Recent Development
11.10 Oxford Nanopore Technologies
11.10.1 Oxford Nanopore Technologies Company Detail
11.10.2 Oxford Nanopore Technologies Business Overview
11.10.3 Oxford Nanopore Technologies MicroRNA Sequencing (miRNA-Seq) Introduction
11.10.4 Oxford Nanopore Technologies Revenue in MicroRNA Sequencing (miRNA-Seq) Business (2019-2024)
11.10.5 Oxford Nanopore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂